Position in DXCM
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$433,320
-$3,925 QoQ
Shares Held
6,900
+4.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 1.9275362318840579.ToString("F0")%
Shared 0.ToString("F0")%
None 98.07246376811595.ToString("F0")%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Inscription Capital, LLC holds $7,920,400 across 12 Medical Devices names. DXCM ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
29,458 | $2,358,996 | |
| 2 | MDT |
Medtronic plc
|
11,326 | $981,397 | |
| 3 | PRCT |
PROCEPT BioRobotics Corp
|
38,082 | $952,430 | |
| 4 | ITGR |
Integer Holdings Corp
|
6,617 | $582,296 | |
| 5 | AVNS |
Avanos Medical, Inc.
|
36,990 | $518,229 | |
| 6 | DXCM |
Dexcom Inc
This page
|
6,900 | $433,320 | |
| 7 | CBLL |
Ceribell, Inc.
|
22,163 | $406,247 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
1,388 | $386,905 |
All Filings in DXCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $433,320 | 6,900 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $437,245 | 6,588 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $239,417 | 3,558 | Shares | Sole | 2025-10-29 | |
| 2025-03-31 | $136,580 | 2,000 | Shares | Sole | 2025-04-17 | |
| 2024-06-30 | $228,460 | 2,015 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $277,400 | 2,000 | Shares | Sole | 2024-07-17 | |
| 2023-12-31 | $248,180 | 2,000 | Shares | Sole | 2024-01-18 | |
| No filing history on record for this holder in this stock. | ||||||